Skip to main content
OpenTrials
Completed

NCT Number: NCT00714454

5% Sodium L-Ascorbyl-2-Phosphate Lotion for the Treatment of Acne Vulgaris

12-week study to compare the efficacy and safety of a course of a twice daily treatment with APS in the form of a lotion to its vehicle for the treatment of acne.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–39 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Miami Cosmetic Center

Miami Beach, Florida, 33140, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject has read, understood, and signed appropriate informed consent, photo consent, and HIPAA consent in their own language.
  • Subject has visible mild to severe acne, as assessed by the investigator.
  • Subject will be available and willing to return for follow-up visits.
  • Subject agrees not to use any other acne treatment products during the study.
  • Subject is otherwise healthy, non-febrile, and is not suffering from an infection likely to require antibiotic therapy during the study period.
  • Subject or guardian must be able to understand the new HIPAA regulations and sign the HIPAA form.
  • Subject is between the ages of 18 and 39.
  • Subject agrees and understands that APS or its vehicle is to be applied to the subject twice daily for 12 weeks; no other topical or systemic medication affecting the course of acne and/or evaluability is to be used during the study.
  • Subject agrees to use only the cleanser, moisturizer with sunscreen, and treatment provided by the study site for the duration of the study.
  • Subject understands and agrees that he/she can not be treated with a systemic antibiotic for acne during the study.
  • Subject agrees he/she will not use an acne topical treatment for two weeks prior to Day 0.

Exclusion criteria

  • Subject or guardian has not signed informed consent, photo consent or HIPAA form.
  • Subject is suffering from a condition likely to require medical attention, including administration of oral or systemic antibiotics, oral or systemic corticosteroids, or any other treatment which in the opinion of the investigator could influence the results of the study.
  • Subject is pregnant or lactating.
  • Subject is suffering from an abnormal skin condition not usually associated with acne.
  • Subject will not be available for follow-up visits.
  • Subject has been previously enrolled in any clinical study in which treatment was received within the past 30 days.
  • Subjects without comedones, papules, pustules, or nodules.
  • Subject has a history of hypersensitivity to any other ingredients of the study lotion.
  • Subject has a history of anaphylaxis.
  • Subject is not able to avoid excessive sun exposure.

Treatment and study plan

APS Topical Lotion

Other

Placebo

Other

Sponsors and collaborators

Lead sponsor

University of Miami

Other

Collaborators

  • Ikeno Clinic

Registry information

Official study title

5% Sodium L-Ascorbyl-2-Phosphate Lotion for the Treatment of Acne Vulgaris: A Double-Blind, Placebo Controlled Trial

Important dates

First posted
Jul 14, 2008
Registry last updated
Jul 14, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.